Matthew Evison

2.3k total citations
85 papers, 675 citations indexed

About

Matthew Evison is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Matthew Evison has authored 85 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 14 papers in Surgery. Recurrent topics in Matthew Evison's work include Lung Cancer Diagnosis and Treatment (48 papers), Lung Cancer Treatments and Mutations (24 papers) and Pleural and Pulmonary Diseases (13 papers). Matthew Evison is often cited by papers focused on Lung Cancer Diagnosis and Treatment (48 papers), Lung Cancer Treatments and Mutations (24 papers) and Pleural and Pulmonary Diseases (13 papers). Matthew Evison collaborates with scholars based in United Kingdom, Italy and France. Matthew Evison's co-authors include Richard Booton, Philip Crosbie, Julie Martin, P.V. Barber, Haval Balata, Julie Morris, Rajesh Shah, Anna Sharman, John Moore and Amelia Clive and has published in prestigious journals such as The Lancet, The Lancet Oncology and CHEST Journal.

In The Last Decade

Matthew Evison

69 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Evison United Kingdom 15 498 149 145 127 103 85 675
C.M. Free United Kingdom 16 449 0.9× 142 1.0× 82 0.6× 45 0.4× 127 1.2× 23 606
Atsushi Kawaguchi Japan 12 482 1.0× 90 0.6× 49 0.3× 137 1.1× 105 1.0× 57 707
Candice L. Wilshire United States 18 426 0.9× 121 0.8× 45 0.3× 71 0.6× 376 3.7× 66 803
Paul MacEachern Canada 18 923 1.9× 83 0.6× 107 0.7× 75 0.6× 316 3.1× 52 1.0k
Mette Siemsen Denmark 11 487 1.0× 100 0.7× 37 0.3× 90 0.7× 205 2.0× 21 631
Ray W. Shepherd United States 12 540 1.1× 41 0.3× 65 0.4× 64 0.5× 200 1.9× 38 698
Caroline Rivera France 14 573 1.2× 142 1.0× 22 0.2× 93 0.7× 212 2.1× 49 750
David F. Yankelevitz United States 10 498 1.0× 92 0.6× 108 0.7× 351 2.8× 112 1.1× 16 775
Sean Grondin Canada 17 475 1.0× 133 0.9× 25 0.2× 87 0.7× 363 3.5× 57 808
Rosa Cordovilla Spain 18 575 1.2× 61 0.4× 52 0.4× 39 0.3× 94 0.9× 54 743

Countries citing papers authored by Matthew Evison

Since Specialization
Citations

This map shows the geographic impact of Matthew Evison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Evison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Evison more than expected).

Fields of papers citing papers by Matthew Evison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Evison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Evison. The network helps show where Matthew Evison may publish in the future.

Co-authorship network of co-authors of Matthew Evison

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Evison. A scholar is included among the top collaborators of Matthew Evison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Evison. Matthew Evison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gourlay, E. S., Kathryn Banfill, Louise Brown, et al.. (2025). Feasibility, acceptability and clinical outcomes of a real-world, regional lung cancer prehabilitation programme for patients undergoing curative intent radiotherapy. Lung Cancer. 204. 108572–108572. 1 indexed citations
2.
Bradley, Stephen H, Matthew Callister, Willy Choon Kon Yune, et al.. (2025). Self-request chest x-ray services—reducing barriers to diagnosis of lung cancer. British Journal of Radiology. 98(1175). 1923–1930.
3.
Evison, Matthew, et al.. (2025). 128 Prehabilitation in patients with advanced stage lung cancer under referred for palliative SACT. Lung Cancer. 200. 108238–108238.
4.
5.
6.
Stanton, Andrew, Mark Juniper, Eihab O. Bedawi, et al.. (2025). Pleural procedural safety in the UK: is everyone’s house in order? Reflections from the BTS National Pleural Service Organisational Audit and a national review of patient safety incidents. BMJ Open Respiratory Research. 12(1). e002840–e002840. 1 indexed citations
7.
Johnston, Janet, Louise Brown, Matthew Callister, et al.. (2024). What Is the Accuracy of Clinical Staging for Stage III-Single-station N2 NSCLC? A Multi-Centre UK Study. JTO Clinical and Research Reports. 5(8). 100694–100694. 2 indexed citations
8.
9.
10.
Stone, Emily, Matthew Evison, Richard N. van Zyl-Smit, et al.. (2023). Recreational vaping ban in Australia—policy failure or masterstroke?. The Lancet. 404(10452). 504–506. 3 indexed citations
11.
Evison, Matthew, Stuart W Grant, Glen P. Martin, et al.. (2021). Adequacy of Mediastinal Lymph Node Sampling in Patients With Lung Cancer Undergoing Lung Resection. Journal of Surgical Research. 270. 271–278. 3 indexed citations
12.
Τzouvelekis, Αrgyris, Κατερίνα Αντωνίου, Michael Kreuter, et al.. (2020). The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus. ERJ Open Research. 7(1). 529–2020. 26 indexed citations
13.
Moore, John, Matthew Evison, G Faulkner, et al.. (2020). Implementing a system-wide cancer prehabilitation programme: The journey of Greater Manchester's ‘Prehab4cancer’. European Journal of Surgical Oncology. 47(3). 524–532. 53 indexed citations
14.
Evison, Matthew, Philip Crosbie, Haval Balata, et al.. (2020). Implementation and outcomes of the RAPID programme: Addressing the front end of the lung cancer pathway in Manchester. Clinical Medicine. 20(4). 401–405. 10 indexed citations
15.
Balata, Haval, Sean Knight, Christopher J. Armitage, et al.. (2019). Attending community-based lung cancer screening influences smoking behaviour in deprived populations. Lung Cancer. 139. 41–46. 15 indexed citations
16.
Franks, K., Lucy McParland, David Baldwin, et al.. (2018). P2.16-16 SABRTOOTH: A Fasibility Study of SABR Versus Surgery in Patients with Peripheral Stage I NSCLC Considered to be at Higher Risk for Surgery. Journal of Thoracic Oncology. 13(10). S837–S837. 1 indexed citations
17.
Berghmans, Thierry, Matthew Evison, Torsten Blum, Nir Peled, & Jacques Cadranel. (2018). New drugs in thoracic oncology: needs and knowledge – an online ERS Lung Cancer Assembly survey. ERJ Open Research. 4(3). 40–2018. 2 indexed citations
18.
Evison, Matthew, Amelia Clive, Helen Powell, et al.. (2017). Resectable Clinical N2 Non–Small Cell Lung Cancer; What Is the Optimal Treatment Strategy? An Update by the British Thoracic Society Lung Cancer Specialist Advisory Group. Journal of Thoracic Oncology. 12(9). 1434–1441. 26 indexed citations
19.
Evison, Matthew, Philip Crosbie, Raffaele Califano, et al.. (2015). Can EBUS-TBNA Provide an Accurate Diagnosis in Patients Found to Have Enlarged or FDG-avid Lymph Nodes During Surveillance of Previously Treated Lung Cancer?. Journal of Bronchology & Interventional Pulmonology. 22(2). 114–120. 5 indexed citations
20.
Evison, Matthew, et al.. (2014). Can computed tomography characteristics predict outcomes in patients undergoing radial EBUS-guided biopsy of peripheral lung lesions?. European Respiratory Journal. 44(Suppl 58). P678–P678. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C.M. Free Breakdown of academic impact, for papers by Atsushi Kawaguchi Breakdown of academic impact, for papers by Candice L. Wilshire Breakdown of academic impact, for papers by Paul MacEachern Breakdown of academic impact, for papers by Mette Siemsen Breakdown of academic impact, for papers by Ray W. Shepherd Breakdown of academic impact, for papers by Caroline Rivera Breakdown of academic impact, for papers by David F. Yankelevitz Breakdown of academic impact, for papers by Sean Grondin Breakdown of academic impact, for papers by Rosa Cordovilla
Rankless by CCL
2026